4//SEC Filing
WYZGA MICHAEL S 4
Accession 0001628280-23-030224
CIK 0001501697other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:09 PM ET
Size
5.2 KB
Accession
0001628280-23-030224
Insider Transaction Report
Form 4
WYZGA MICHAEL S
Director
Transactions
- Purchase
Common Stock
2023-08-18$1.20/sh+25,000$29,875→ 76,667 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at $1.195 and $1.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth in this footnote.
- [F2]Of the shares of common stock reported, 48,333 shares represent restricted stock units.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001201256
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 4:09 PM ET
- Size
- 5.2 KB